West Midlands Academic Health Science Network

Tony Davis

West Midlands AHSN interim board

Background

• Innovation, Health & Wealth – published December 11 set out a plan for spreading innovation through the NHS

• Focus that innovation is vital in order to transform healthcare

• Aim to rapidly spread change to improve quality, safety and productivity

Role and purpose of AHSNs

• Improve the identification, adoption, spread, speed of innovation and good practice in the NHS

• Provide the opportunity to align education and training, clinical research, informatics, innovation and healthcare delivery

• Enable the NHS and academia to work collaboratively with industry

• Overall purpose to improve patient outcomes and create wealth

• Succeed where others have not

West Midlands - background

• 5.6m diverse population• Inequality in health outcomes and healthcare delivery• Academic & clinical excellence, established regional

networks and collaborations • Industrial heritage that will drive wealth creation

WM AHSN aims

• To transform the identification, adoption spread and spread of innovation and good practice

• To align healthcare delivery, research, education and training

• To drive wealth creation through the development of a regional industry portal enabling access to the NHS, driving adoption and publishing evaluation

• To improve outcomes - driven through use of digital platforms

Strategy & vision – 6 enabling themes• Develop a novel and comprehensive digital framework• Establish regional clinical trials platforms - support for

acceleration, reducing bureaucracy, improving efficiency and cost effectiveness

• To promote and accelerate innovation, evaluation and adoption

• To drive and develop patient-centric integrated care pathways - bridging primary, secondary & social care

• Focus on education & training - delivering a fit for purpose workforce in partnership with LETB

• To create wealth - proactive support for regional medical technology industry engagement

Initial focus on 3 clinical priorities

• Mental health– In the young – Dementia (carers, community management)

• Long Term Conditions– Diabetes & obesity– Musculoskeletal disease

• Drug safety– From hospital to primary care– Abolishing prescribing errors across the region

Organisations involved in AHSN development to date

• University Hospitals Coventry and Warwickshire NHS Trust• University Hospitals Birmingham NHS Foundation Trust• University of Birmingham• Keele University• Birmingham and Solihull Mental Health Foundation Trust• University Hospital North Staffordshire NHS Foundation

Trust• University of Warwick• Heart of England NHS Foundation Trust• West Midlands South CLRN • Medilink West Midlands

Organisation & governance

MEMBERS ownership and overall

responsibility for the AHSN

STAKEHOLDERS &

PARTNERS sector

cohesion via stakeholder reference

groups

EXECUTIVEresponsibility

for the execution

and delivery of the

strategy

AHSN board – from September 2013

• Chair • MD• COO• Spoke chairs x 3 and hub chair x 1• HEIs x 3• MH / community trust CEO• Commercial representative • LETB (non voting) • CRN (non voting)

Current position

• Designated without condition on 13th May 2013 (7 of the 15 had conditions)

• £4.63 million funding for 2013/14 – given in two parts (£3.2m in July and £1.43 later)

• Discussions regarding on further funding on-going

Our hope 5 years on…

• To have an integrated & innovative health network – not just in words

• To be the first UK regional digital healthcare economy • To be the known place for industry for NHS access,

evaluation and adoption• To be significantly on the road to reversing health

inequality and to have significantly improved outcomes for the region

Questions?